Begin main content

Alemtuzumab

Last Updated: October 1, 2013
Result type: Reports
Project Number: SR0355
Product Line: Common Drug Review

Generic Name: Alemtuzumab

Brand Name: Lemtrada

Manufacturer: Genzyme Canada, a Division of sanofi-aventis Canada Inc.

Indications: Multiple Sclerosis, relapsing

Submission Type: Pre-NOC

Project Status: Withdrawn